 | • レポートコード：GIR201103713 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、乱用薬物検査の世界市場を調査対象にし、乱用薬物検査の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（精神刺激薬、麻薬、幻覚剤、鎮静剤、その他）、用途別分析（病院、診断研究所、法医学研究所、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Quest Diagnostics、Thermo Fisher Scientific、F. Hoffmann La-Roche、Laboratory Corporation of America、Siemens、Shimadzu、Abbott ・メーカー別販売量、売上、市場シェア ・乱用薬物検査の地域別市場分析 ・乱用薬物検査の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・乱用薬物検査のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・乱用薬物検査のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・乱用薬物検査の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・乱用薬物検査の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・乱用薬物検査の種類別市場規模2015-2020：精神刺激薬、麻薬、幻覚剤、鎮静剤、その他 ・乱用薬物検査の用途別市場規模2015-2020：病院、診断研究所、法医学研究所、その他 ・乱用薬物検査の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Drugs of Abuse Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3516 million by 2025, from USD 2957.6 million in 2019.
The Drugs of Abuse Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drugs of Abuse Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drugs of Abuse Testing market has been segmented into
Psychostimulants
Narcotic
Hallucinogens
Sedatives
Others
By Application, Drugs of Abuse Testing has been segmented into:
Hospitals
Diagnostics Laboratories
Forensic Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs of Abuse Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs of Abuse Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs of Abuse Testing market.
The report offers in-depth assessment of the growth and other aspects of the Drugs of Abuse Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Drugs of Abuse Testing Market Share Analysis
Drugs of Abuse Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs of Abuse Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs of Abuse Testing sales, revenue and market share for each player covered in this report.
The major players covered in Drugs of Abuse Testing are:
Quest Diagnostics
Thermo Fisher Scientific
F. Hoffmann La-Roche
Laboratory Corporation of America
Siemens
Shimadzu
Abbott
Among other players domestic and global, Drugs of Abuse Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs of Abuse Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs of Abuse Testing, with price, sales, revenue and global market share of Drugs of Abuse Testing in 2018 and 2019.
Chapter 3, the Drugs of Abuse Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs of Abuse Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drugs of Abuse Testing market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drugs of Abuse Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Drugs of Abuse Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs of Abuse Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Psychostimulants
1.2.3 Narcotic
1.2.4 Hallucinogens
1.2.5 Sedatives
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs of Abuse Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Forensic Laboratories
1.3.5 Others
1.4 Overview of Global Drugs of Abuse Testing Market
1.4.1 Global Drugs of Abuse Testing Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Quest Diagnostics
2.1.1 Quest Diagnostics Details
2.1.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Quest Diagnostics SWOT Analysis
2.1.4 Quest Diagnostics Product and Services
2.1.5 Quest Diagnostics Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann La-Roche
2.3.1 F. Hoffmann La-Roche Details
2.3.2 F. Hoffmann La-Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann La-Roche SWOT Analysis
2.3.4 F. Hoffmann La-Roche Product and Services
2.3.5 F. Hoffmann La-Roche Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Laboratory Corporation of America
2.4.1 Laboratory Corporation of America Details
2.4.2 Laboratory Corporation of America Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Laboratory Corporation of America SWOT Analysis
2.4.4 Laboratory Corporation of America Product and Services
2.4.5 Laboratory Corporation of America Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Siemens
2.5.1 Siemens Details
2.5.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Siemens SWOT Analysis
2.5.4 Siemens Product and Services
2.5.5 Siemens Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Shimadzu
2.6.1 Shimadzu Details
2.6.2 Shimadzu Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Shimadzu SWOT Analysis
2.6.4 Shimadzu Product and Services
2.6.5 Shimadzu Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott SWOT Analysis
2.7.4 Abbott Product and Services
2.7.5 Abbott Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drugs of Abuse Testing Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drugs of Abuse Testing Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs of Abuse Testing Manufacturer Market Share in 2019
3.3.2 Top 6 Drugs of Abuse Testing Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drugs of Abuse Testing Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs of Abuse Testing Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drugs of Abuse Testing Revenue and Market Share by Regions (2015-2020)
4.2 North America Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
4.3 Europe Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
4.5 South America Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drugs of Abuse Testing Sales, Revenue and Market Share by Country
5.1.1 North America Drugs of Abuse Testing Sales and Market Share by Country (2015-2020)
5.1.2 North America Drugs of Abuse Testing Revenue and Market Share by Country (2015-2020)
5.2 United States Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
5.3 Canada Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
5.4 Mexico Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drugs of Abuse Testing Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs of Abuse Testing Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drugs of Abuse Testing Revenue and Market Share by Country (2015-2020)
6.2 Germany Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
6.3 UK Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
6.4 France Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
6.5 Russia Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
6.6 Italy Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drugs of Abuse Testing Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drugs of Abuse Testing Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drugs of Abuse Testing Revenue and Market Share by Regions (2015-2020)
7.2 China Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
7.3 Japan Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
7.4 Korea Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
7.5 India Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
7.7 Australia Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drugs of Abuse Testing Sales, Revenue and Market Share by Country
8.1.1 South America Drugs of Abuse Testing Sales and Market Share by Country (2015-2020)
8.1.2 South America Drugs of Abuse Testing Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
8.3 Argentina Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Drugs of Abuse Testing Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Drugs of Abuse Testing Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Drugs of Abuse Testing Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
9.3 Turkey Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
9.4 Egypt Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
9.5 South Africa Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drugs of Abuse Testing Sales and Market Share by Type (2015-2020)
10.2 Global Drugs of Abuse Testing Revenue and Market Share by Type (2015-2020)
10.3 Global Drugs of Abuse Testing Price by Type (2015-2020)
11 Global Drugs of Abuse Testing Market Segment by Application
11.1 Global Drugs of Abuse Testing Sales Market Share by Application (2015-2020)
11.2 Global Drugs of Abuse Testing Revenue Market Share by Application (2015-2020)
11.3 Global Drugs of Abuse Testing Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drugs of Abuse Testing Sales, Revenue and Growth Rate (2021-2025)
12.2 Drugs of Abuse Testing Market Forecast by Regions (2021-2025)
12.2.1 North America Drugs of Abuse Testing Market Forecast (2021-2025)
12.2.2 Europe Drugs of Abuse Testing Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drugs of Abuse Testing Market Forecast (2021-2025)
12.2.4 South America Drugs of Abuse Testing Market Forecast (2021-2025)
12.2.5 Middle East & Africa Drugs of Abuse Testing Market Forecast (2021-2025)
12.3 Drugs of Abuse Testing Market Forecast by Type (2021-2025)
12.3.1 Global Drugs of Abuse Testing Sales Forecast by Type (2021-2025)
12.3.2 Global Drugs of Abuse Testing Market Share Forecast by Type (2021-2025)
12.4 Drugs of Abuse Testing Market Forecast by Application (2021-2025)
12.4.1 Global Drugs of Abuse Testing Sales Forecast by Application (2021-2025)
12.4.2 Global Drugs of Abuse Testing Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Drugs of Abuse Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs of Abuse Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs of Abuse Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 8. Quest Diagnostics Drugs of Abuse Testing Major Business
Table 9. Quest Diagnostics Drugs of Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 10. Quest Diagnostics SWOT Analysis
Table 11. Quest Diagnostics Drugs of Abuse Testing Product and Services
Table 12. Quest Diagnostics Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 14. Thermo Fisher Scientific Drugs of Abuse Testing Major Business
Table 15. Thermo Fisher Scientific Drugs of Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 16. Thermo Fisher Scientific SWOT Analysis
Table 17. Thermo Fisher Scientific Drugs of Abuse Testing Product and Services
Table 18. Thermo Fisher Scientific Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. F. Hoffmann La-Roche Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann La-Roche Drugs of Abuse Testing Major Business
Table 21. F. Hoffmann La-Roche Drugs of Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 22. F. Hoffmann La-Roche SWOT Analysis
Table 23. F. Hoffmann La-Roche Drugs of Abuse Testing Product and Services
Table 24. F. Hoffmann La-Roche Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Laboratory Corporation of America Basic Information, Manufacturing Base and Competitors
Table 26. Laboratory Corporation of America Drugs of Abuse Testing Major Business
Table 27. Laboratory Corporation of America Drugs of Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 28. Laboratory Corporation of America SWOT Analysis
Table 29. Laboratory Corporation of America Drugs of Abuse Testing Product and Services
Table 30. Laboratory Corporation of America Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Siemens Basic Information, Manufacturing Base and Competitors
Table 32. Siemens Drugs of Abuse Testing Major Business
Table 33. Siemens Drugs of Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 34. Siemens SWOT Analysis
Table 35. Siemens Drugs of Abuse Testing Product and Services
Table 36. Siemens Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 38. Shimadzu Drugs of Abuse Testing Major Business
Table 39. Shimadzu Drugs of Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 40. Shimadzu SWOT Analysis
Table 41. Shimadzu Drugs of Abuse Testing Product and Services
Table 42. Shimadzu Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Abbott Basic Information, Manufacturing Base and Competitors
Table 44. Abbott Drugs of Abuse Testing Major Business
Table 45. Abbott Drugs of Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 46. Abbott SWOT Analysis
Table 47. Abbott Drugs of Abuse Testing Product and Services
Table 48. Abbott Drugs of Abuse Testing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Drugs of Abuse Testing Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Drugs of Abuse Testing Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Drugs of Abuse Testing Sales by Regions (2015-2020) (K Units)
Table 52. Global Drugs of Abuse Testing Sales Market Share by Regions (2015-2020)
Table 53. Global Drugs of Abuse Testing Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Drugs of Abuse Testing Sales by Countries (2015-2020) (K Units)
Table 55. North America Drugs of Abuse Testing Sales Market Share by Countries (2015-2020)
Table 56. North America Drugs of Abuse Testing Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Drugs of Abuse Testing Revenue Market Share by Countries (2015-2020)
Table 58. Europe Drugs of Abuse Testing Sales by Countries (2015-2020) (K Units)
Table 59. Europe Drugs of Abuse Testing Sales Market Share by Countries (2015-2020)
Table 60. Europe Drugs of Abuse Testing Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Drugs of Abuse Testing Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Drugs of Abuse Testing Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Drugs of Abuse Testing Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Drugs of Abuse Testing Sales by Countries (2015-2020) (K Units)
Table 65. South America Drugs of Abuse Testing Sales Market Share by Countries (2015-2020)
Table 66. South America Drugs of Abuse Testing Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Drugs of Abuse Testing Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Drugs of Abuse Testing Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Drugs of Abuse Testing Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Drugs of Abuse Testing Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Drugs of Abuse Testing Revenue Market Share by Countries (2015-2020)
Table 72. Global Drugs of Abuse Testing Sales by Type (2015-2020) (K Units)
Table 73. Global Drugs of Abuse Testing Sales Share by Type (2015-2020)
Table 74. Global Drugs of Abuse Testing Revenue by Type (2015-2020) (USD Million)
Table 75. Global Drugs of Abuse Testing Revenue Share by Type (2015-2020)
Table 76. Global Drugs of Abuse Testing Sales by Application (2015-2020) (K Units)
Table 77. Global Drugs of Abuse Testing Sales Share by Application (2015-2020)
Table 78. Global Drugs of Abuse Testing Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Drugs of Abuse Testing Market Share Forecast by Regions (2021-2025)
Table 80. Global Drugs of Abuse Testing Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Drugs of Abuse Testing Market Share Forecast by Type (2021-2025)
Table 82. Global Drugs of Abuse Testing Sales Forecast by Application (2021-2025)
Table 83. Global Drugs of Abuse Testing Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drugs of Abuse Testing Picture
Figure 2. Global Sales Market Share of Drugs of Abuse Testing by Type in 2019
Figure 3. Psychostimulants Picture
Figure 4. Narcotic Picture
Figure 5. Hallucinogens Picture
Figure 6. Sedatives Picture
Figure 7. Others Picture
Figure 8. Drugs of Abuse Testing Sales Market Share by Application in 2018
Figure 9. Hospitals Picture
Figure 10. Diagnostics Laboratories Picture
Figure 11. Forensic Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Drugs of Abuse Testing Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Drugs of Abuse Testing Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Drugs of Abuse Testing Sales Market Share by Manufacturer in 2019
Figure 34. Global Drugs of Abuse Testing Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Drugs of Abuse Testing Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Drugs of Abuse Testing Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Drugs of Abuse Testing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Drugs of Abuse Testing Revenue Market Share by Regions (2015-2020)
Figure 41. Global Drugs of Abuse Testing Revenue Market Share by Regions in 2018
Figure 42. North America Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
Figure 43. Europe Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
Figure 45. South America Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Drugs of Abuse Testing Sales and Growth Rate (2015-2020)
Figure 47. North America Drugs of Abuse Testing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Drugs of Abuse Testing Sales Market Share by Countries (2015-2020)
Figure 49. North America Drugs of Abuse Testing Sales Market Share by Countries in 2018
Figure 50. North America Drugs of Abuse Testing Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Drugs of Abuse Testing Revenue Market Share by Countries in 2018
Figure 52. United States Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Drugs of Abuse Testing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Drugs of Abuse Testing Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Drugs of Abuse Testing Revenue Market Share by Countries in 2019
Figure 58. Germany Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Drugs of Abuse Testing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Drugs of Abuse Testing Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Drugs of Abuse Testing Revenue Market Share by Regions 2019
Figure 66. China Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Drugs of Abuse Testing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Drugs of Abuse Testing Sales Market Share by Countries in 2019
Figure 73. South America Drugs of Abuse Testing Revenue Market Share by Countries in 2019
Figure 74. Brazil Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Drugs of Abuse Testing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Drugs of Abuse Testing Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Drugs of Abuse Testing Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Drugs of Abuse Testing Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Drugs of Abuse Testing Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Drugs of Abuse Testing Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Drugs of Abuse Testing Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Drugs of Abuse Testing Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Drugs of Abuse Testing Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Drugs of Abuse Testing Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Drugs of Abuse Testing Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
感染症検査機器の世界市場 2020年 Market Overview The Infectious Disease Testing Instrumentation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…- 獣医迅速検査キットの世界市場 2020年 Market Overview The Veterinary Rapid Testing Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 凝固検査消耗品の世界市場 2020年 Market Overview The global Coagulation Testing Consumables market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coagulation T…
- ポイントオブケア検査（POCT）の世界市場 2020年 Market Overview The Point-of-Care Testing (POCT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- ポイントオブケア検査（POCT）デバイスの世界市場 2020年 Market Overview The global Point-of-Care Testing (POCT) Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Point-of…